Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
2.020
0.00 (0.00%)
Mar 9, 2026, 1:36 PM EDT - Market open
Pulmatrix Employees
Pulmatrix had 2 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,581,000
Market Cap
7.38M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 117 |
| KALA BIO | 38 |
| Kiora Pharmaceuticals | 12 |
| Alzamend Neuro | 7 |
| Immuron | 7 |
| Ernexa Therapeutics | 6 |
| Addex Therapeutics | 2 |
| PharmaCyte Biotech | 2 |
PULM News
- 7 days ago - Pulmatrix Announces Termination of Prior Planned Merger and Continues Pursuit of Alternative Merger Opportunities - PRNewsWire
- 11 days ago - Pulmatrix Announces Year-End and Fourth Quarter 2025 Financial Results - PRNewsWire
- 2 months ago - Pulmatrix and Cullgen Continue to Pursue Merger While Granting Each Other Waivers to Explore Alternatives - PRNewsWire
- 5 months ago - Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets - PRNewsWire
- 7 months ago - Pulmatrix Announces Second Quarter 2025 Financial Results and Divestment Plan for Inhalation Assets - PRNewsWire
- 10 months ago - Pulmatrix Announces First Quarter 2025 Financial Results and Divestment Plan for Assets - PRNewsWire
- 10 months ago - PULMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pulmatrix, Inc. - PULM - Business Wire
- 1 year ago - Pulmatrix Announces Year-End and Fourth Quarter 2024 Financial Results and Divestment Plan for Assets - PRNewsWire